李彧，女，1973年4月生，博士，研究员，主要从事中医药防治多器官纤维化的研究。教育部创新团队负责人，教育部、国家外专局中西医结合学科创新引智基地中方骨干。主要社会兼职有中华中医药学会肾病分会常委，中国实验方剂学杂志编委。2011年获首届中西医结合优秀青年贡献奖。第六批全国老中医药专家学术经验继承人。主持国家自然基金委面上项目2项（No.81573716，81173642）、青年基金项目1项(No.30600819)，参与国家自然基金委、科技部、教育部、北京市各级各类课题20余项。发表学术论文30余篇，其中SCI论文11篇。获省部级奖励一等奖2项，二等奖3项，三等奖2项。

　　近年来发表论文

　　[1] Wang XT, Sun XJ, Li C, Liu Y, Zhang L, Li YD, Wu QH, Li SY, Li Y*. Establishing a Cell-Based High-Content Screening Assay for TCM Compounds with Anti-Renal Fibrosis Effects. Evid Based Complement Alternat Med. 2018, 28:7942614. (通讯作者）

　　[2] 刘祎,王曦廷,张澜,孙雪娇,韩森,唐磊,李亚东,李彧*.姜黄素对大鼠肾间质成纤维细胞中小分子RNA-21及纤维化相关因子表达的影响[J].北京中医药大学学报,2018,41(06):476-481.（通讯作者）

　　[3] Tang YQ, Li C, Sun XJ, Liu Y, Wang XT, Guo YB, Wang LL, Ma RF, Niu JZ, Fu M, Zhang DW*, Li Y*. Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats. BMC Complement Altern Med. 2018 Apr 2;18(1):118. (通讯作者)

　　[4] 王曦廷,刘祎,张澜,李彧*.基于数据挖掘的牛建昭教授治疗更年期综合征用药规律研究[J].世界科学技术-中医药现代化, 2017,19(10):1680-1686.(通讯作者)

　　[5] 刘祎,孙雪娇,李城,王曦廷,李彧*. MicroRNA-29在肾纤维化进程中的研究进展[J]. 解剖学报,2017,48(05):622-627.(通讯作者)

　　[6] Liu C, Ma R, Wang L, Zhu R, Liu H, Guo Y, Zhao B, Zhao S, Tang J, Li Y, Niu J, Fu M, Zhang D*, Gao S*. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. Journal of Ethnopharmacology l. 2017, 198:351-362.

　　[7] Ma R, Wang L, Zhao B, Liu C, Liu H, Zhu R, Chen B, Li L, Zhao D, Mo F, Li Y, Niu J, Jiang G, Fu M, Bromme D, Gao S*, Zhang D*. Diabetes Perturbs Bone Microarchitecture and Bone Strength through Regulation of Sema3A/IGF-1/β-Catenin in Rats. Cellular Physiology Biochemistry. 2017;41(1):55-66.

　　[8] Xuejiao Sun,Yi Liu, Cheng Li, Xiting Wang, Ruyuan Zhu,Chenyue Liu,Haixia Liu,Lili Wang,Rufeng Ma,Min Fu,Dongwei Zhang, and Yu Li*.Recent Advances of Curcumin in the Prevention andTreatment of Renal Fibrosis. BioMed Research International,Volume 2017, https://doi.org/10.1155/2017/2418671. (通讯作者)

　　[9] Lili Wang, Rufeng Ma, Chenyue Liu, Haixia Liu, Ruyuan Zhu, Shuzhen Guo, Minke Tang, Yu Li, Jianzhao Niu, Min Fu, Sihua Gao, and Dongwei Zhang. Salvia miltiorrhiza: A Potential Red Light to the Development of CardiovascularDiseases. Current Pharmaceutical Design, 2017, 23, 1077-1097

　　[10] 孙雪娇,刘祎,李城,王曦廷,吴清华,张宇欣,栗世铀,李亚东,李彧*. 抗肾纤维化药物高内涵筛选模型的建立及应用[J]. 中国药理学通报, 2017,33(3):327-334. (通讯作者)

　　[11] Rufeng Ma, Ruyuan Zhu, Lili Wang, Yubo Guo, Chenyue Liu, Haixia Liu,Fengwei Liu, Hongjun Li, Yu Li, Min Fu, and Dongwei Zhang. Diabetic Osteoporosis: A Review of Its Traditional Chinese Medicinal Use and Clinical and Preclinical Research. Evidence-Based Complementary and Alternative Medicine. Volume 2016, http://dx.doi.org/10.1155/2016/3218313

　　[12] 唐雨晴,张东伟,孙雪娇,郭鱼波,王丽丽,马如风,李城,刘祎,李彧*. 补肾活血方对去卵巢大鼠子宫ER及Cyclin B表达影响的实验研究[J].北京中医药大学学报. 2016(04)：281-287. (通讯作者)

　　[13] Xu-yanFu, Dong-wei Zhang, Yu Li*, Pi-wen Zhao, Yu-qing Tang. Curcumin Treatment Suppresses CCR7 Expression and the Differentiation and Migration of Human Circulating Fibrocytes. Cell Physiol Biochem, 2015,35:489-498 (通讯作者)

　　[14] Yubo Guo, Yu Li, Liming Xue, Richele P. Severino, Sihua Gao, Jianzhao Niu, Lu-Ping Qin, Dongwei Zhang. An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs. Journal of Ethnopharmacology.2014.07.058

　　[15] Qiu Q, Li C, Wang Y, Xiao C, Li Y, Lin Y, Wang W. Plasma metabonomics study on Chinese medicine syndrome evolution of heart failure rats caused by LAD ligation. BMC Compl. Alter. Med. 2014, 9;14:232.

　　[16] Qiu Q, Lin Y, Xiao C, Li C, Wang Y, Yang K, Suo W, Li Y, Chuo W, Wei Y, Wang W. Time-Course of the Effects of QSYQ in Promoting Heart Function in Ameroid Constrictor-Induced Myocardial Ischemia Pigs. Evid Based Complement Alternative Med. 2014:571076.

　　[17] 富徐燕,赵丕文,李亚东,唐雨晴,牛建昭,王鸿捷,李彧*. 姜黄素对人循环纤维细胞增殖及COLⅠ表达影响的研究[J]. 中国药理学通报,2014,07:942-947. (通讯作者)